Year archive

Lineage Cell Therapeutics Inc. — 2025 filings

All 67 regulatory filings released by Lineage Cell Therapeutics Inc. (LCTX) in 2025, sourced directly from the official regulator.

67 Filings

2025 Period

2025 filings (67)

Filing	Released	Lang
4 Filing Director's Dealing	2025-12-19	English
4 Filing Director's Dealing	2025-12-19	English
8-K Regulatory Filings	2025-11-28	English
8-K Regulatory Filings	2025-11-24	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-11-15	English
8-K Regulatory Filings	2025-11-12	English
424B3 Regulatory Filings	2025-11-12	English
Immediate Report Earnings Release Q3 2025	2025-11-09	English
Immediate Report Report Publication Announcement	2025-11-09	English
10-Q Interim / Quarterly Report Q3 2025	2025-11-06	English
8-K Regulatory Filings	2025-11-06	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-09-26	English
Regulatory Filings 2025 Regulatory Filings	2025-09-24	English
Regulatory Filings 2025 Regulatory Filings	2025-09-10	English
Immediate Report Regulatory Filings	2025-09-08	English
Immediate Report Report Publication Announcement	2025-09-08	English
8-K Regulatory Filings	2025-08-26	English
S-8 Regulatory Filings	2025-08-15	English
Second Quarter 2025 Financial Results and Provides Business Update Earnings Release Q2 2025	2025-08-13	English
Second Quarter 2025 Financial Results and Provides Business Update Report Publication Announcement	2025-08-13	English
10-Q Interim / Quarterly Report Q2 2025	2025-08-12	English
8-K Regulatory Filings	2025-08-12	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-07-18	English
Director's Dealing 2025 Director's Dealing	2025-07-03	English
FORM 4- STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP - Jayasuriya Anula Director's Dealing	2025-07-03	Hebrew (modern)
FORM 4- STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP - Jayasuriya Anula Director's Dealing	2025-07-03	English
FORM4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP - Mulroy Michael H. Director's Dealing	2025-07-03	Hebrew (modern)
FORM4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP - Mulroy Michael H. Director's Dealing	2025-07-03	English
FORM 8-K-The Annual Meeting - final voting results AGM Information	2025-07-03	Hebrew (modern)
FORM 8-K-The Annual Meeting - final voting results Declaration of Voting Results & Voting Rights Announcements	2025-07-03	English
4 Director's Dealing	2025-07-03	English
4 Director's Dealing	2025-07-03	English
4 Director's Dealing	2025-07-03	English
4 Director's Dealing	2025-07-03	English
4 Director's Dealing	2025-07-03	English
8-K Regulatory Filings	2025-07-02	English
NOTICE OF ANNUAL MEETING OF SHAREHOLDERS To Be Held June 26, 2025 Remuneration Information	2025-06-23	English
NOTICE OF ANNUAL MEETING OF SHAREHOLDERS To Be Held June 26, 2025 Proxy Solicitation & Information Statement	2025-06-23	English
8-K Regulatory Filings	2025-06-23	English
DEFA14A Regulatory Filings	2025-06-11	English
8-K Regulatory Filings	2025-06-09	English
First Quarter 2025 Financial Results and Provides Business Update Earnings Release Q1 2025	2025-05-14	English
First Quarter 2025 Financial Results and Provides Business Update Report Publication Announcement	2025-05-14	English
The company's financial results for the First quarter of 2025 were reported abroad Report Publication Announcement	2025-05-14	Hebrew (modern)
10-Q Interim / Quarterly Report Q1 2025	2025-05-13	English
8-K Regulatory Filings	2025-05-13	English
8-K Regulatory Filings	2025-05-01	English
ARS Annual Report	2025-04-29	English
DEFA14A Regulatory Filings	2025-04-29	English
DEF 14A Proxy Solicitation & Information Statement	2025-04-29	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-04-24	English
4 Director's Dealing	2025-03-12	English
4 Director's Dealing	2025-03-12	English
4 Director's Dealing	2025-03-12	English
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update Earnings Release Q4 2024	2025-03-11	English
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update Report Publication Announcement	2025-03-11	English
The company's financial results for the Fourth quarter and full year 2024 were reported abroad Regulatory Filings	2025-03-11	Hebrew (modern)
10-K Annual Report FY 2024	2025-03-10	English
8-K Regulatory Filings	2025-03-10	English
4 Director's Dealing	2025-02-12	English
4 Director's Dealing	2025-02-12	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-02-05	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-01-29	English
Director's Dealing 2025 Director's Dealing	2025-01-29	English
Lineage Cell Therapeutics Announces Closing of Second Tranche of Previously Announced Registered Direct Offering Share Issue/Capital Change	2025-01-28	English
Lineage Cell Therapeutics Announces Closing of Second Tranche of Previously Announced Registered Direct Offering Capital/Financing Update	2025-01-28	English
8-K Regulatory Filings	2025-01-27	English

Filings by year

2026 38 filings
2025 67 filings
2024 156 filings
2023 121 filings
2022 190 filings
2021 273 filings
2020 185 filings
2019 269 filings
2018 215 filings
2017 354 filings
2016 227 filings
2015 186 filings
2014 116 filings
2013 125 filings
2012 95 filings
2011 63 filings
2010 97 filings